OBIOOrchestra BioMed Holdings, Inc.vs its industry peers
A metric-by-metric comparison of Orchestra BioMed Holdings, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OBIOEsta | $347M#7 | — | 3.5x#4 | 10.4x#6 | 1169.2%#1 | 13.6%#4 | -154.7%#6 | -52.8%#5 | -54.9%#5 | — | 53.9%#2 | 5.8%#2 |
| NPCE | $425M#1 | — | 35.7x#6 | 4.2x#3 | 25.1%#4 | 20.9%#3 | -16.3%#3 | -180.6%#6 | -28.0%#4 | 4#4 | 31.8%#3 | — |
| CARL | $409M#2 | 136.3x#3 | 4.9x#5 | 8.1x#4 | 85.9%#2 | -22.2%#5 | -60.5%#5 | -35.2%#4 | -57.3%#6 | 5#2 | 21.1%#4 | — |
| SI | $404M#3 | 0.1x#1 | 3.3x#3 | 8.5x#5 | 49.6%#3 | -158.4%#6 | -55.6%#4 | -32.5%#3 | -22.9%#3 | 3#5 | 72.5%#1 | — |
| MOBI | $357M#4 | — | 2.1x#2 | — | — | — | — | 0.0%#1 | — | — | — | — |
| OFIX | $353M#5 | — | 0.8x#1 | 0.4x#2 | 2.9%#5 | 26.8%#1 | -9.9%#2 | -21.5%#2 | -14.9%#2 | 5#2 | -46.0%#5 | — |
| EMBC | $348M#6 | 4.2x#2 | — | 0.3x#1 | -3.8%#6 | 21.8%#2 | 22.4%#1 | — | 27.0%#1 | 6#1 | -49.6%#6 | 10.1%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice